Skip to Content

WPI 845 (Glipizide Extended Release 10 mg)

Pill with imprint WPI 845 is White, Round and has been identified as Glipizide Extended Release 10 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 845

Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845  Front
Glipizide extended release 10 mg WPI 845  Back
Glipizide extended release 10 mg WPI 845  Front
Glipizide extended release 10 mg WPI 845  Back
Glipizide extended release 10 mg WPI 845
Glipizide extended release 10 mg WPI 845

Glipizide Extended Release

Imprint
WPI 845
Strength
10 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
acetyltributyl citrate, ammonia, butyl alcohol, ferrosoferric oxide, hydroxyethyl cellulose (2000 cps at 1%), isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 400, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-0845 Watson Pharmaceuticals, Inc.
68084-0112 Amerisource Health Services
10370-0191 Anchen Pharmaceuticals, Inc.
54569-5548 A-S Medication Solutions, LLC (repackager)
54868-4988 Physicians Total Care Inc. (repackager)
55289-0301 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "WPI 845"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.